Raymond James & Associates Scholar Rock Holding Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Raymond James & Associates holds 119,835 shares of SRRK stock, worth $5.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,835
Previous 68,478
75.0%
Holding current value
$5.3 Million
Previous $570,000
68.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRRK
# of Institutions
178Shares Held
75.5MCall Options Held
585KPut Options Held
862K-
Siren, L.L.C. New York, NY11.3MShares$498 Million4.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.65MShares$383 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$300 Million31.52% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$250 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.24MShares$232 Million2.74% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.28B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...